Key Insight From The Trading Updates of 3 FTSE Stocks – Associated British Foods Plc, Dechra Pharmaceuticals Plc and Kier Group Plc

Key Insight From The Trading Updates of 3 FTSE Stocks – Associated British Foods Plc, Dechra Pharmaceuticals Plc and Kier Group Plc

Associated British Foods Plc

Associated British Foods Plc (LON: ABF) is a London, United Kingdom based food production company that is engaged in the diversified business of food, ingredients and retail business. The group’s major businesses include Sugar, Ingredients, Grocery, Agriculture and Retail. The company caters its products primarily to industries including Agriculture, Pharmaceutical, Retail and Food.

ABF Trading Update

On 16th January 2020, the company made a press release to present a trading update for a period of 16 weeks to 4th of January 2020. In terms of the group revenue for the period, the company reported that it is expected to be 4 per cent ahead of what it was for the same period in the last year. In terms of the retail segment, it was reported that the sales were 4.5 per cent higher as compared to the last year on a constant currency and 3 per cent on the actual exchange rate basis. The company also highlighted that their outlook for the overall group performance remains unchanged, and they expect some progress in adjusted earnings per share for the year.

ABF Share Price Performance

(Source: Thomson Reuters) Daily Chart as on 16-January-20, before the closing of the LSE Market

On 16th January 2020, at around 10:35 A.M Greenwich Mean Time, at the time of covering the details, Associated British Foods Plc’s share price was reportedly at GBX 2617.00 per share on the London Stock Exchange market, a jump in the price of 2.43 per cent or GBX 62.00 per share, as opposed to the last trading day’s closing price, that was reportedly at GBX 2555.00 per share. The market capitalisation of Associated British Foods Plc was reported to be at £20.227 billion with regards, to the price at which the company’s share was trading at the time of writing.

The company’s share has shown a positive change of around 19.57 per cent, in the year gone by, from the price of GBX 2188.69, at which the company’s share was trading as on January 16, 2019. The Associated British Foods Plc share has also given a positive return in the last six months, of approximately 13.14 per cent compared to the share price of GBX 2313.00 which was set by Associated British Foods Plc’s share as on July 16, 2019. The company’s share has though given a negative return of around 0.53 per cent, in last one month’s time from the share price of GBX 2631.00 per share that it achieved at the close of the market on December 16, 2019.

The company’s stock beta was reported at 1.00, which denotes that the Associated British Foods Plc’s share as fickle as the benchmark index in the last one year.

Dechra Pharmaceuticals Plc

Dechra Pharmaceuticals Plc (LON: DPH) is a Northwich, United Kingdom based Pharmaceuticals and Biotechnology company, which is into development, manufacturing and commercialisation of veterinary pharmaceuticals and related products business. It manufactures Companion Animal, Equine and Animal food & nutrition products. The most prominent of the company’s drugs are Vetoryl® for Cushing’s disease in dogs and Felimazole® for hyperthyroidism in cats. The company’s shares were admitted on the London Stock Exchange for trading in the year 2000. The shares of the company are also constituents of the FTSE 250 index.

DPH Trading Update

The company issued a trading statement for the half-year ended 31st December 2019 on 16th January 2020. The company highlighted that the overall net revenue was up by 7 per cent year on year at constant exchange rates (CER). The net revenue growth from the European pharmaceutical segment was reported to be at 13 per cent year on year on CER. The company reported the completion of the integration of Venco and Caledonian acquisitions that they made during the period. The company also highlighted the previously made announcement regarding the acquisition of the assets of Osurnia, which is likely to be completed in a span of 12 months. The company highlighted that it would present its interim results for this half-year period on 24th February 2020.

DPH Share Price Performance

(Source: Thomson Reuters) Daily Chart as on 16-January-20, before the closing of the LSE Market

On 16th January 2020, at around 10:40 A.M Greenwich Mean Time, at the time of covering the details, Dechra Pharmaceuticals Plc’s share price was reportedly at GBX 2936.00 per share on the London Stock Exchange market, a fall in the price of 4.30 per cent or GBX 132.00 per share, as opposed to the last trading day’s closing price, that was reportedly at GBX 3068.00 per share. The market capitalisation of Dechra Pharmaceuticals Plc was reported to be at £3.155 billion with regards, to the price at which the company’s share was trading at the time of writing.

The company’s share has shown a positive change of around 22.44 per cent, in the year gone by, from the price of GBX 2398.00, at which the company’s share was trading as on January 16, 2019. The Dechra Pharmaceuticals Plc share has given a negative return in the last six months, of approximately 0.34 per cent compared to the share price of GBX 2946.00 which was set by Dechra Pharmaceuticals Plc’s share as on July 16, 2019. The company’s share has though given a positive return of around 5.23 per cent, in last one month’s time from the share price of GBX 2790.00 per share that it achieved at the close of the market on December 16, 2019.

The company’s stock beta was reported at 0.60, which denotes that the Dechra Pharmaceuticals Plc’s share has been less volatile in nature, in comparison to the sensitivity of the benchmark index in the previous year.

Kier Group Plc

Kier Group Plc (LON: KIE) is a construction and property development company specialised in residential and commercial property development and infrastructure project investment. The company caters its services to various sectors including utilities, power, housing, defence, institutional, commercial, education and industrial sectors. Woodford Investment Management Ltd, Aberdeen Standard Investments and BlackRock Advisors (UK) Ltd are the top institutional investors in the company.

KIE Trading Update

On 16th January 2020, the company came with an update regarding the trading that took place between the period of 15th November 2019 and 31st December 2019. The company reported that trading for the period was in line with the expectations of the management. It was highlighted that the company was appointed to all 20 lots of the four-year £8 billion Procure Partnerships Framework. The company confirmed the previously announced statement that Matthew Lester was appointed as the Chairman of the Board of Directors during the period, that came into effect from 1st January 2020. The company highlighted that they would be presenting their interim results for the six months period ending 31st December 2019 in between 5th March and 20th March 2020.

KIE Share Price Performance

(Source: Thomson Reuters) Daily Chart as on 16-January-20, before the closing of the LSE Market

On 16th January 2020, at around 10:45 A.M Greenwich Mean Time, at the time of covering the details, Kier Group Plc’s share price was reportedly at GBX 79.65 per share on the London Stock Exchange market, a jump in the price of 2.77 per cent or GBX 2.15 per share, as opposed to the last trading day’s closing price, that was reportedly at GBX 77.50 per share. The market capitalisation of Kier Group Plc was reported to be at £125.64 million with regards, to the price at which the company’s share was trading at the time of writing.

The company’s share has shown a negative change of around 84.59 per cent, in the year gone by, from the price of GBX 517.00, at which the company’s share was trading as on January 16, 2019. The Kier Group Plc share has also given a negative return in the last six months, of approximately 6.29 per cent compared to the share price of GBX 85.00 which was set by Kier Group Plc’s share as on July 16, 2019. The company’s share has also given a negative return of around 17.29 per cent, in last one month’s time from the share price of GBX 96.30 per share that it achieved at the close of the market on December 16, 2019.

The company’s stock beta was reported at -0.39, which denotes that the Kier Group Plc’s share is inversely correlated to the sensitivity of the benchmark index in the previous year.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK